Cargando…

Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington’s Disease

BACKGROUND: Advances in molecular therapeutic approaches in the last decade are translating into the design of non-traditional clinical trials. In order to improve their feasibility, it is important to understand the attitudes of potential participants towards these trials, their motivations to get...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bardakjian, Tanya M., Naczi, Kaylee Faulkner, Gonzalez-Alegre, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398921/ https://www.ncbi.nlm.nih.gov/pubmed/30689592 http://dx.doi.org/10.3233/JHD-180328

Ejemplares similares

Healthcare delivery via telehealth during the COVID-19 pandemic: The experience of a Huntington’s disease clinic
por: Klapper, Jennifer, et al.
Publicado: (2021)

Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington’s Disease Community
por: Cotter, Kristina, et al.
Publicado: (2019)

A Novel SPAST/SPG4 Splice-Site Variant in a Family with Dominant Hereditary Spastic Paraplegia
por: Robbins, Nathaniel M., et al.
Publicado: (2020)

Predicting Severity of Huntington's Disease With Wearable Sensors
por: Scheid, Brittany H., et al.
Publicado: (2022)

Knowledge, Attitudes and Perceptions of Saudis towards Participating in Clinical Trials
por: AL-Tannir, Mohamad A., et al.
Publicado: (2016)

Huntington's disease: from gene to potential therapy
por: Lehrach, Hans, et al.
Publicado: (2001)

Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis
por: Hamedani, Ali G., et al.
Publicado: (2020)

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials
por: Jenkins, V, et al.
Publicado: (2010)

Knowledge and Attitudes of Guam Residents towards Cancer Clinical Trial Participation
por: Taafaki, Munirih R., et al.
Publicado: (2022)

Molecular Research on Huntington’s Disease
por: Valor, Luis M.
Publicado: (2023)

Characteristics, attitudes, and the odds for positive attitude toward clinical trial: A study on Indonesian COVID-19 vaccine trial participants
por: Maharani, Nani, et al.
Publicado: (2023)

Patients’ Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial
por: Edelman, Malou, et al.
Publicado: (2019)

Chinese Cancer Patients’ Attitudes Toward Psychotherapy and Their Willingness to Participate in Clinical Trials of Psychotherapy
por: Zeng, Zhi, et al.
Publicado: (2022)

Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation
por: Hsiao, Cheng-Tsung, et al.
Publicado: (2021)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
por: Jurcau, Anamaria
Publicado: (2022)

Clinicians’ attitudes towards clinical trials of cancer therapy
por: Ford, E, et al.
Publicado: (2011)

A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2023)

Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer
por: Kuderer, Nicole M., et al.
Publicado: (2017)

Towards an Understanding of Energy Impairment in Huntington’s Disease Brain
por: Dubinsky, Janet M.
Publicado: (2017)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Attitudes Toward Psychological Disorders and Alternative Medicine in Saudi Participants
por: Alegiry, Mohamed H., et al.
Publicado: (2021)

Attitudes towards Participation in a Passive Data Collection Experiment
por: Ságvári, Bence, et al.
Publicado: (2021)

University student-teachers’ diversity and attitudes toward classroom participation
por: Rugambuka, Innocent Buberwa, et al.
Publicado: (2023)

A Novel Therapy for Huntington’s Disease
por: La Spada, Albert R.
Publicado: (2018)

A Glimpse of Molecular Biomarkers in Huntington’s Disease
por: Martí-Martínez, Silvia, et al.
Publicado: (2022)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
por: Júlio, Filipa, et al.
Publicado: (2021)

Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study
por: Mao, Jun J, et al.
Publicado: (2014)

Physicians’ Attitudes towards and Reasons for Participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
por: Rahman, Mahbubur, et al.
Publicado: (2005)

Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
por: Lukacena, Kaylee M., et al.
Publicado: (2022)

Uncovering the Genetic and Molecular Features of Huntington’s Disease in Northern Colombia
por: Ahmad, Mostapha, et al.
Publicado: (2023)

Public attitudes in Japan toward participation in whole genome sequencing studies
por: Okita, Taketoshi, et al.
Publicado: (2018)

Construction and Piloting of Attitude Towards Research Participation Scale for University Students
por: Khan, Khatib Ahmad, et al.
Publicado: (2021)

Social participation and attitude towards gerontechnology: The moderating role of frailty status
por: Lee, Ka Yeon, et al.
Publicado: (2021)

Glycation potentiates neurodegeneration in models of Huntington’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2016)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Pain in Huntington’s disease and its potential mechanisms
por: Li, Jiajie, et al.
Publicado: (2023)

Advocacy Recruiting for Huntington’s Disease Clinical Trials
por: Goodman, LaVonne, et al.
Publicado: (2011)

Novel circuitry and molecular pathogenic mechanisms in Huntington's disease
por: Yang, X William
Publicado: (2012)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

Molecular Mechanisms Underlying Muscle Wasting in Huntington’s Disease
por: Bozzi, Manuela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gr4v0o82makob3ihph68vsshsc